← Back to Search

Psychotherapy for Cancer

N/A
Recruiting
Led By Christian Nelson, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
As per self-report or medical record, has a diagnosis of cancer
As per self-report or medical record, ≥ 70 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights

Study Summary

This trial is testing a new cancer intervention called CARE to see if it's more effective than the standard intervention, SWSC, in treating depression and distress.

Who is the study for?
This trial is for older adults (70+) with cancer, who are currently undergoing treatment or have been treated within the past 6 months. They should be able to care for themselves mostly (KPRS score ≥ 60), think clearly (BOMC ≤ 11), and speak English well. It's not for those in hospice care, unable to consent, on new antidepressants (<3 months), or with untreated major psychotic disorders.Check my eligibility
What is being tested?
The study tests a new psychotherapy called CARE against an existing therapy known as SWSC. Both aim to reduce depression and distress in older cancer patients through five phone sessions. The effectiveness of each method will be compared.See study design
What are the potential side effects?
Since this trial involves psychotherapy interventions rather than medications, traditional side effects like you might see with drugs aren't expected. However, participants may experience emotional discomfort discussing personal issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with cancer.
Select...
I am 70 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression and Anxiety: Hospital Anxiety and Depression Scale (HADS)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Social Work and Supportive Counseling (SWSC)Experimental Treatment1 Intervention
The SWSC will include a social work assessment and follow-up augmented with additional components of supportive psychotherapy that have been shown to be an effective form of treatment for patients with cancer. Five sessions (45-60 minutes each) will be delivered over an 8-week period (+4 weeks). Following these sessions, four brief booster sessions (20-30 minutes each) will be delivered at a rate of approximately one per month to extend the interventions to 6 months (+3 months).
Group II: Cancer and Aging: Reflections for Elders (CARE) InterventionExperimental Treatment1 Intervention
Session content and timing was developed and confirmed in our qualitative work (Expert Panel) and the CARE pilot study. Five sessions (45-60 minutes each) will be delivered over an 8-week period (+4 weeks). Following these sessions, four brief booster sessions (20-30 minutes each) will be delivered at a rate of approximately one per month to extend the interventions to 6 months (+3 months).

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,934 Previous Clinical Trials
588,508 Total Patients Enrolled
Christian Nelson, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
10 Previous Clinical Trials
2,275 Total Patients Enrolled

Media Library

Cancer and Aging: Reflections for Elders (CARE) Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04452825 — N/A
Cancer Research Study Groups: Cancer and Aging: Reflections for Elders (CARE) Intervention, Social Work and Supportive Counseling (SWSC)
Cancer Clinical Trial 2023: Cancer and Aging: Reflections for Elders (CARE) Intervention Highlights & Side Effects. Trial Name: NCT04452825 — N/A
Cancer and Aging: Reflections for Elders (CARE) Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04452825 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of participants in this clinical trial?

"Accurate. Clinicaltrials.gov data reveals that the study, which was originally posted on February 1st 2021, is actively recruiting individuals for participation at a single clinical site with a target enrollment of 296 participants."

Answered by AI

Are there opportunities for patients to be enrolled in this trial at present?

"Affirmative. Clinicaltrials.gov informs that this research project, which was initially made public on February 1st 2021 is currently enrolling patients. Specifically, 296 participants are needed from one location."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
65+
What site did they apply to?
Memorial Sloan Kettering Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. Memorial Sloan Kettering Cancer Center: < 48 hours
Average response time
  • < 2 Days
~74 spots leftby Jun 2025